Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation (Q31036740)

28 June 2017

title

Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation (English)

1 reference

28 June 2017

Hideharu Abe

1

1 reference

28 June 2017

Takeshi Matsubara

2

1 reference

28 June 2017

Noriyuki Iehara

3

1 reference

28 June 2017

Kojiro Nagai

4

1 reference

28 June 2017

Toshikazu Takahashi

5

1 reference

28 June 2017

Hidenori Arai

6

1 reference

28 June 2017

Toru Kita

7

1 reference

28 June 2017

Toshio Doi

8

1 reference

28 June 2017

language of work or name

English

0 references

publication date

19 January 2004

1 reference

Journal of Biological Chemistry

28 June 2017

published in

1 reference

28 June 2017

volume

279

1 reference

28 June 2017

issue

14

1 reference

28 June 2017

page(s)

14201-14206

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

The mesangial cell: a tissue culture view

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Cloning of the large subunit of activator 1 (replication factor C) reveals homology with bacterial DNA ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Rb interacts with histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

T-box gene tbx5 is essential for formation of the pectoral limb bud.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Characterization of a bone morphogenetic protein-responsive Smad-binding element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Smad3 mutant mice develop metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Advanced glycation end products, oxidant stress and vascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Identifiers

DOI

10.1074/JBC.M310427200

1 reference

28 June 2017

1 reference